Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axa Parenterals is an established Indian pharmaceutical manufacturer specializing in sterile parenteral preparations including large and small volume injectables, infusions, pre-filled syringes, lyophilized products, liposomal formulations, ophthalmic solutions, and respules. The company holds WHO-GMP and PIC/S certifications with exports to over 61 countries. Its portfolio covers critical care medicines such as propofol, liposomal amphotericin B, enoxaparin sodium injection prefilled syringes, heparin injections, levetiracetam ampoules/vials for neurology indications among others. It operates both as a branded supplier in India and as a contract manufacturer/CDMO internationally[1][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axa Parenterals.